759
Views
6
CrossRef citations to date
0
Altmetric
Research Article

DaoTan decoction (DTD) inhibits tumor necrosis factor-α (TNF-α)-induced expression of intercellular adhesion molecule-1 (ICAM-1), p53 and p21, in human umbilical vein endothelia cells (HUVECs)

, , , , &
Pages 1320-1326 | Received 23 Oct 2013, Accepted 31 Jan 2014, Published online: 15 Jul 2014

References

  • Akca H, Yenisoy S, Yanikoglu A, Ozes ON. (2002). Tumor necrosis factor-alpha-induced accumulation of tumor suppressor protein p53 and cyclin-dependent protein kinase inhibitory protein p21 is inhibited by insulin in ME-180S cells. Clin Chem Lab Med 40:764–8
  • Aoki M, Morishita R, Matsushita H, et al. (1999). Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth. Hypertension 34:192–200
  • Barak Y, Juven T, Haffner R, Oren M. (1993). mdm2 expression is induced by wild type p53 activity. EMBO J 12:461–8
  • Bevilacqua MP. (1993). Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 11:767–804
  • Bochu W, Liancai Z, Qi C. (2005). Primary study on the application of serum pharmacology in Chinese traditional medicine. Colloids Surf B Biointerfaces 43:194–7
  • Chen CY, Oliner JD, Zhan Q, et al. (1994). Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci USA 91:2684–8
  • Chen H. (2001). Clinical effect of daotan decoction on fatty liver. Chin J Integr Med 21:457–8
  • Chen W, Li Z, Huang X, et al. (2008). Influence of daotan decoction on the expression of ICAM-1 in cerebrovascular endothelial cells of rat. Chin J Inf Trad Chin Med 15:28–9
  • Duan X, Huang S. (2011). Clinical observation on 68 cases of angina pectoris treated by daotan decoction. Hun J Trad Chin Med 27:12–4
  • Dustin ML, Rothlein R, Bhan AK, et al. (1986). Induction by IL 1 and interferon-gamma: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137:245–54
  • el-Deiry WS, Tokino T, Velculescu VE, et al. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75:817–25
  • Geng YJ. (2001). Biologic effect and molecular regulation of vascular apoptosis in atherosclerosis. Curr Atheroscler Rep 3:234–42
  • Gorgoulis VG, Pratsinis H, Zacharatos P, et al. (2005). p53-dependent ICAM-1 overexpression in senescent human cells identified in atherosclerotic lesions. Lab Invest 85:502–11
  • Gorgoulis VG, Zacharatos P, Kotsinas A, et al. (2003). p53 activates ICAM-1 (CD54) expression in an NF-kappaB-independent manner. EMBO J 22:1567–78
  • Guo X. (2000). The research of daotan decoction on hyperlipidemia. Chin J Tradit Chin Med Pharm 15:71–2
  • Gupta P, Balwani S, Kumar S, et al. (2010). beta-Sitosterol among other secondary metabolites of Piper galeatum shows inhibition of TNFalpha-induced cell adhesion molecule expression on human endothelial cells. Biochimie 92:1213–21
  • Güray U, Erbay AR, Güray Y, et al. (2004). Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis. Int J Cardiol l96:235–40
  • Gutiérrez G, Mendoza C, Zapata E, et al. (2007). Dehydroepiandrosterone inhibits the TNF-alpha-induced inflammatory response in human umbilical vein endothelial cells. Atherosclerosis 190:90–9
  • Haverslag R, Pasterkamp G, Hoefer IE. (2008). Targeting adhesion molecules in cardiovascular disorders. Cardiovasc Hematol Disord Drug Targets 8:252–60
  • He G, Siddik ZH, Huang Z, et al. (2005). Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene 24:2929–43
  • Hsu SP, Lee WS. (2011). Progesterone receptor activation of extranuclear signaling pathways in regulating p53 expression in vascular endothelial cells. Mol Endocrinol 25:421–32
  • Huang F, Yao GX, Huang XL, Liu YN. (2007). Clinical observation on acupuncture for treatment of hypertension of phlegm-stasis blocking collateral type. Zhong guo Zhen Jiu 27:403–6
  • Huang X, Wang F, Chen W, et al. (2012). Dao-Tan decoction inhibits tumor necrosis factor-α-induced intercellular adhesion molecule-1 expression by blocking JNK and p38 signaling pathways in human umbilical vein endothelial cells. Pharm Biol 50:1111–17
  • Hunter T, Pines J. (1994). Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79:573–82
  • Huo Y, Ley K. (2001). Adhesion molecules and atherogenesis. Acta Physiol Scand 173:35–43
  • Igata M, Motoshima H, Tsuruzoe K, et al. (2005). Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circ Res 97:837–44
  • Ihling C, Menzel G, Wellens E, et al. (1997). Topographical association between the cyclin-dependent kinases inhibitor p21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue. Arterioscler Thromb Vasc Biol 17:2218–24
  • Jaffe EA, Nachman RL, Becker CG, Minick CR. (1973). Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745–56
  • Jain M, Parmar HS. (2011). Evaluation of antioxidative and anti-inflammatory potential of hesperidin and naringin on the rat air pouch model of inflammation. Inflamm Res 60:483–91
  • Kaplanski G, Marin V, Fabrigoule M, et al. (1998). Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). Blood 92:1259–67
  • Kim HJ, Yoo EK, Kim JY, et al. (2009). Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells. Arterioscler Thromb Vasc Biol 29:1558–64
  • Kubbutat MH, Jones SN, Vousden KH. (1997). Regulation of p53 stability by Mdm2. Nature 387:299–303
  • Lakatta EG. (2003). Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises: Part III: Cellular and molecular clues to heart and arterial aging. Circulation 107:490–7
  • Lei Y, Wang ZH, Zhao H, Liu JG. (2009). Study of the relationship between carotid intima-media thickness and traditional Chinese medicine syndrome of dyslipidemia. Chin J Integr Med 15:112–16
  • Levine AJ. (1997). p53, the cellular gatekeeper for growth and division. Cell 88:323–31
  • Liu Jia, Wang F. (2009). From the sputum on the treatment of coronary heart disease and angina. J Pract Tradit Chin Intern Med 12:36–7
  • Marín J. (1995). Age-related changes in vascular responses: A review. Mech Ageing Dev 79:71–114
  • Minamino T, Yoshida T, Tateno K, et al. (2003). Ras induces vascular smooth muscle cell senescence and inflammation in human atherosclerosis. Circulation 108:2264–9
  • Misra UK, Pizzo SV. (2010). PFT-alpha inhibits antibody-induced activation of p53 and pro-apoptotic signaling in 1-LN prostate cancer cells. Biochem Biophys Res Commun 391:272–6
  • Momand J, Zambetti GP, Olson DC, et al. (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237–45
  • Peng G, Niu H, Xu L. (2001). Studies on the active constituents offructus aurantii immaturus. J Nanj TCM Un 17:91–2
  • Rivard A, Berthou-Soulie L, Principe N, et al. (2000). Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem 275:29643–7
  • Rivard A, Fabre JE, Silver M, et al. (1999). Age-dependent impairment of angiogenesis. Circulation 99:111–20
  • Ross R, Glomset JA. (1973). Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 180:1332–9
  • Ross R. (1993). The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801–9
  • Schneiderman J, Sawdey MS, Keeton MR, et al. (1992). Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA 89:6998–7002
  • Smith CW, Marlin SD, Rothlein R, et al. (1989). Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 83:2008–17
  • Song JN, Liu JL, Fang XZ, et al. (2008). Relationship between plasma protein expression profiles and states of Zang-Fu organs in patients with phlegm or blood stagnation syndromes due to hyperlipidemia and atherosclerosis. Zhong Xi Yi Jie He Xue Bao 6:1233–7
  • Staunton DE, Marlin SD, Stratowa C, et al. (1988). Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 52:925–33
  • Sun Z. (2009). 43 Headache patients of phlegm and blood stasis syndrome were treated by dissolving phlegm and blood method. J Em Trad Chin Med 18:1156–7
  • Wang J, Huang S, Xu Z. (2008). Effect of gualou xiebai banxia decocation on metablism of proteoglycans in aorta in rabbits of atherosclerosis model. Chin J Art 16:290–2
  • Wang Y, Li X, Deng Z, et al. (1986). 158 stroke patients were treated by dissolving phlegm and bowel relaxing method. Chin J Trad Chin Med Pharm 2:86–8
  • Wei H, Xie F, Rao Y, et al. (2010). Determination of flavone ingredients in Citrus aurantium, bitter orange immature, walnut peel and tangerine peel by internal standard multi-control method. Chin J Exp Trad Med Form 16:75–7
  • Wilkerson WR, Sane DC. (2002). Aging and thrombosis. Semin Thromb Hemost 28:555–68
  • Zhang H. (2008). Daotan decoction is used in treating with 30 hemorrhagic stroke patients. Guid J Trad Chin Med Pharm 14:26–7
  • Zhang Q, Zheng Y, Zhang R, Jiang H. (1996). Experimental studies on the anti-oxidation action of the tuber of Pedate Pinellia (Pinellia Pedatisecta) and the root of common monkshood (Acoitum carmichaeli). Chin Trad Herb Drugs 27:544–6
  • Zhang X. (1998). 32 High blood lipid patients were treated by dissolving phlegm method. Beij J Trad Chin Med 5:33–4
  • Zhao Q, Guo H, Cui G. (2009). The similarity research of several Araceae medicinal plants. Heb Med J 31:2975–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.